Your browser is no longer supported. Please, upgrade your browser.
WST [NYSE]
West Pharmaceutical Services, Inc.
IndexS&P 500 P/E68.34 EPS (ttm)5.58 Insider Own0.50% Shs Outstand73.90M Perf Week1.98%
Market Cap27.61B Forward P/E48.93 EPS next Y7.79 Insider Trans-0.59% Shs Float73.35M Perf Month6.24%
Income423.10M PEG2.65 EPS next Q1.74 Inst Own95.40% Short Float1.53% Perf Quarter17.73%
Sales2.33B P/S11.87 EPS this Y42.50% Inst Trans0.19% Short Ratio2.92 Perf Half Y26.99%
Book/sh24.75 P/B15.40 EPS next Y9.08% ROA16.10% Target Price351.60 Perf Year45.41%
Cash/sh6.68 P/C57.08 EPS next 5Y25.80% ROE24.10% 52W Range253.75 - 377.19 Perf YTD34.51%
Dividend0.68 P/FCF106.93 EPS past 5Y28.70% ROI15.90% 52W High1.03% Beta0.99
Dividend %0.18% Quick Ratio2.10 Sales past 5Y8.90% Gross Margin37.50% 52W Low50.18% ATR5.82
Employees9200 Current Ratio2.70 Sales Q/Q36.50% Oper. Margin21.30% RSI (14)70.78 Volatility2.00% 1.45%
OptionableYes Debt/Eq0.14 EPS Q/Q102.70% Profit Margin18.20% Rel Volume0.62 Prev Close373.98
ShortableYes LT Debt/Eq0.14 EarningsJul 29 BMO Payout11.50% Avg Volume383.60K Price381.07
Recom2.00 SMA203.40% SMA508.44% SMA20025.01% Volume236,327 Change1.90%
Nov-10-20Initiated KeyBanc Capital Markets Overweight $350
Oct-14-20Initiated Stephens Equal-Weight $300
Jul-21-20Upgrade BofA Securities Neutral → Buy $280
Apr-24-20Upgrade BofA/Merrill Underperform → Neutral $145 → $200
Dec-12-19Downgrade BofA/Merrill Neutral → Underperform
Jul-26-19Upgrade BofA/Merrill Underperform → Neutral
May-01-19Downgrade Jefferies Buy → Hold $122
Apr-23-19Initiated William Blair Outperform
Apr-25-18Downgrade BofA/Merrill Neutral → Underperform
Jan-24-18Initiated Goldman Neutral
Oct-17-17Downgrade BofA/Merrill Buy → Neutral
Oct-03-17Initiated Stephens Equal-Weight
Sep-15-17Upgrade Jefferies Hold → Buy
Oct-28-16Upgrade Wells Fargo Market Perform → Outperform
Sep-21-16Downgrade Wells Fargo Outperform → Market Perform
Mar-22-16Initiated Wells Fargo Outperform
May-14-10Reiterated UBS Neutral $41 → $44
Feb-23-10Initiated Jefferies & Co Buy $45
Dec-19-08Initiated UBS Neutral $41
Dec-19-08Initiated UBS Neutral
Jul-15-21 03:01PM  
06:00AM  
Jul-13-21 10:15AM  
Jul-09-21 07:16AM  
Jul-06-21 09:51AM  
09:19AM  
08:27AM  
Jun-30-21 04:56PM  
12:02PM  
Jun-23-21 09:44AM  
09:41AM  
Jun-21-21 09:40AM  
Jun-16-21 06:32AM  
Jun-08-21 10:11AM  
08:30AM  
Jun-07-21 09:04AM  
Jun-01-21 04:03PM  
10:02AM  
May-28-21 12:45PM  
May-25-21 10:40AM  
06:00AM  
May-20-21 11:22AM  
May-12-21 05:32PM  
09:11AM  
May-10-21 10:47AM  
May-07-21 08:44AM  
May-06-21 09:11AM  
May-05-21 06:00AM  
Apr-30-21 09:15AM  
Apr-29-21 12:31PM  
07:15AM  
06:00AM  
Apr-22-21 12:33PM  
Apr-17-21 08:00AM  
Apr-15-21 06:00AM  
Apr-13-21 09:17AM  
Apr-06-21 01:42PM  
Mar-31-21 12:30PM  
Mar-17-21 06:00AM  
Mar-16-21 09:07AM  
Mar-11-21 09:47AM  
Mar-10-21 09:53AM  
Mar-04-21 10:15AM  
Feb-24-21 04:30PM  
Feb-18-21 02:01PM  
07:40AM  
06:45AM  
06:00AM  
Feb-15-21 08:42AM  
Feb-04-21 06:00AM  
Jan-30-21 08:00AM  
Jan-29-21 04:32PM  
11:26AM  
Jan-25-21 10:23AM  
Jan-19-21 07:17AM  
Jan-06-21 01:19PM  
Dec-24-20 06:24AM  
Dec-23-20 10:12AM  
Dec-22-20 07:03AM  
Dec-16-20 07:56AM  
Dec-15-20 10:57AM  
Dec-14-20 11:40AM  
11:30AM  
Dec-09-20 06:00AM  
Dec-08-20 12:33PM  
Dec-05-20 04:00PM  
Dec-03-20 10:25AM  
Dec-01-20 05:03AM  
Nov-27-20 11:30AM  
Nov-13-20 08:00AM  
Nov-12-20 10:11AM  
Nov-11-20 11:30AM  
08:38AM  
Nov-10-20 10:31AM  
08:25AM  
Nov-09-20 04:30PM  
10:17AM  
09:30AM  
Nov-06-20 11:05AM  
11:00AM  
10:14AM  
09:15AM  
08:46AM  
Nov-05-20 02:12PM  
10:34AM  
09:00AM  
08:55AM  
Nov-04-20 08:20AM  
Nov-03-20 10:05AM  
09:47AM  
09:17AM  
08:29AM  
08:19AM  
Nov-02-20 12:34PM  
11:13AM  
10:55AM  
10:45AM  
10:43AM  
Oct-30-20 11:49AM  
10:45AM  
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Abraham SiljiChief Digital & Trans OfficerMay 10Sale335.002,171727,2856,077May 10 04:49 PM
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.Nov 06Option Exercise62.309,000560,70016,540Nov 09 06:36 PM
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.Nov 06Sale296.679,0002,670,0417,540Nov 09 06:36 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 29Option Exercise83.475,358447,2329,582Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 29Sale270.703,273886,0146,309Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 28Option Exercise74.3313,7921,025,16818,732Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 28Sale264.8214,5083,842,0474,224Jul 30 06:22 PM